BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 2239593)

  • 1. [Correlation between histologic grading and prognosis of prostatic cancer--comparing the grading system of the Japanese general rules of prostatic cancer with Gleason's grading].
    Hioki T; Sugimura Y; Sakurai M; Hayashi N; Tochigi H; Kawamura J; Yatani R
    Hinyokika Kiyo; 1990 Aug; 36(8):921-6. PubMed ID: 2239593
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Correlation between histological grading and the prognosis of prostatic carcinoma--a comparative study of the Japanese General Rules of Prostatic Cancer (JGRPC) and Gleason's classification].
    Uchida T; Go M; Nakajo H; Takagi Y; Murayama M; Honda N; Igarashi M; Ishibashi A; Koshiba K
    Hinyokika Kiyo; 1988 Jan; 34(1):116-22. PubMed ID: 3376792
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of Japanese general rules of prostatic cancer and Gleason grading system.
    Fukagai T; Namiki T; Carlile RG; Sugawara S; Morita M; Shimada M; Yoshida H; Namiki H
    Int J Urol; 2001 Oct; 8(10):539-45; discussion 546-8. PubMed ID: 11737480
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Histologic grading of primary prostatic carcinoma--study of Gleason histologic grading].
    Uchijima Y; Kusuyama H; Okada K
    Hinyokika Kiyo; 1987 Aug; 33(8):1193-8. PubMed ID: 3425519
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Reproducibility and prognostic value of Gleason's and Gaeta's histological grades in prostatic carcinoma].
    Rousselet MC; Saint-André JP; Six P; Soret JY
    Ann Urol (Paris); 1986; 20(5):317-22. PubMed ID: 3777875
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic criteria in patients with prostate cancer: Gleason score versus volume-weighted mean nuclear volume.
    Fujikawa K; Sasaki M; Arai Y; Yamabe H; Ogawa O; Yoshida O
    Clin Cancer Res; 1997 Apr; 3(4):613-8. PubMed ID: 9815728
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Prognostic significance of clinical stage including extent of disease (EOD) in prostate cancer].
    Fujinami K; Kondo I; Miura T; Harada M; Uemura H; Hosaka M; Kawasaki C
    Hinyokika Kiyo; 1998 Apr; 44(4):259-63. PubMed ID: 9617622
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impact of the 2005 international society of urological pathology consensus conference on standard Gleason grading of prostatic carcinoma in needle biopsies.
    Billis A; Guimaraes MS; Freitas LL; Meirelles L; Magna LA; Ferreira U
    J Urol; 2008 Aug; 180(2):548-52; discussion 552-3. PubMed ID: 18550106
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adenocarcinoma of the prostate in Iceland: a population-based study of stage, Gleason grade, treatment and long-term survival in males diagnosed between 1983 and 1987.
    Jonsson E; Sigbjarnarson HP; Tomasson J; Benediktsdottir KR; Tryggvadottir L; Hrafnkelsson J; Olafsdottir EJ; Tulinius H; Jonasson JG
    Scand J Urol Nephrol; 2006; 40(4):265-71. PubMed ID: 16916765
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trends in distribution and prognostic significance of Gleason grades on radical retropubic prostatectomy specimens between 1989 and 2001.
    Sengupta S; Slezak JM; Blute ML; Leibovich BC; Sebo TJ; Myers RP; Cheville JC; Bergstralh EJ; Zincke H
    Cancer; 2006 Jun; 106(12):2630-5. PubMed ID: 16703592
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Comparisons of histological grading between biopsy and radical prostatectomy specimens in prostatic adenocarcinoma].
    Fujinami K; Satomi Y; Sugawara T; Ikeda I; Ohgo Y; Harada M
    Nihon Hinyokika Gakkai Zasshi; 1995 Sep; 86(9):1460-5. PubMed ID: 7474635
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The value of cytological grading of prostatic adenocarcinoma. Comparison of the clinical state, the Gleason score and grade in 69 cases].
    Piaton E; Mouriquand J; Berger N; Mouriquand P; Seigneurin D; Devonec M; Perrin P
    J Urol (Paris); 1990; 96(4):211-6. PubMed ID: 2212719
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Histologic grade in penile squamous cell carcinoma: visual estimation versus digital measurement of proportions of grades, adverse prognosis with any proportion of grade 3 and correlation of a Gleason-like system with nodal metastasis.
    Chaux A; Torres J; Pfannl R; Barreto J; Rodriguez I; Velazquez EF; Cubilla AL
    Am J Surg Pathol; 2009 Jul; 33(7):1042-8. PubMed ID: 19384189
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lymphovascular invasion is an independent prognostic factor in prostatic adenocarcinoma.
    Cheng L; Jones TD; Lin H; Eble JN; Zeng G; Carr MD; Koch MO
    J Urol; 2005 Dec; 174(6):2181-5. PubMed ID: 16280760
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Reproducibility of malignancy grading in prostatic cancers using the Gleason-Böckling system].
    Kiss F; Lakner G; Csellár M; Nagy P; Tóth A; Vittay G
    Orv Hetil; 1997 May; 138(19):1195-9. PubMed ID: 9235527
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prediction of pelvic lymph node metastasis by the ratio of cathepsin B to stefin A in patients with prostate carcinoma.
    Sinha AA; Quast BJ; Wilson MJ; Fernandes ET; Reddy PK; Ewing SL; Gleason DF
    Cancer; 2002 Jun; 94(12):3141-9. PubMed ID: 12115346
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low Gleason score prostatic adenocarcinomas are no longer viable entities.
    Berney DM
    Histopathology; 2007 May; 50(6):683-90. PubMed ID: 17493232
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic factors for survival of patients with pathological Gleason score 7 prostate cancer: differences in outcome between primary Gleason grades 3 and 4.
    Lau WK; Blute ML; Bostwick DG; Weaver AL; Sebo TJ; Zincke H
    J Urol; 2001 Nov; 166(5):1692-7. PubMed ID: 11586204
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Gleason's score: update in 2008].
    Molinié V
    Ann Pathol; 2008 Oct; 28(5):350-3. PubMed ID: 19068389
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Gleason's system and pelvic lymphadenectomy in the pretherapeutic evaluation of cancer of the prostate. Apropos of 85 cases].
    Luciani L; Coccarelli F; Pusiol T; Piscioli F
    J Urol (Paris); 1988; 94(2):87-9. PubMed ID: 3392408
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.